DCB
DCB is a medical device with 7 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
3
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis
A Cohort Study of PCI Strategies for Severely Calcified Lesions of Complex Coronary Arteries in the Elderly
Comparison of DCB and DES for Severe Calcification of de Novo Lesion in Elderly CHD
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
Clinical Trials (7)
IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis
A Cohort Study of PCI Strategies for Severely Calcified Lesions of Complex Coronary Arteries in the Elderly
Comparison of DCB and DES for Severe Calcification of de Novo Lesion in Elderly CHD
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
Clinical Efficacy and Safety of a Prospective, Multicenter Drug Coated Balloon for Left Main Artery Disease in China
Systematic Review and Meta-Analysis on DCB vs. POBA in De-novo Femoropopliteal Disease
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7